These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6176796)

  • 41. A comparison between metoprolol and pindolol in the treatment of essential hypertension.
    Tuomilehto J; Pohjola M
    Ann Clin Res; 1978 Feb; 10(1):24-9. PubMed ID: 28070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

  • 43. [Acute tolerance to the hypotensive effect of pindolol in spontaneously hypertensive rats (SHR)].
    Matsunaga K; Ueda M
    Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):259-66. PubMed ID: 6141128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
    Hansson L; Dahlof B
    Am J Cardiol; 1987 Jan; 59(3):137B-140B. PubMed ID: 2949584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The long-term effect of isradipine in pindolol-treated patients.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term blood pressure control with pindolol given once daily.
    Frithz G; Danielson M; Henningsen N; Malmborg RO; Nordström-Ohrberg G; Schröder G
    Eur J Cardiol; 1978; 7(2-3):131-6. PubMed ID: 27369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension.
    Wong GW; Boyda HN; Wright JM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD007450. PubMed ID: 25427719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative study of the central nervous system effect of the beta receptor blockaders pindolol and bisoprolol].
    Görtelmeyer R; Klingmann I
    Arzneimittelforschung; 1985; 35(11):1707-10. PubMed ID: 2936354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Single daily dose of pindolol in the treatment of arterial hypertension].
    Ciaramelli F
    Nouv Presse Med; 1978 Sep; 7(31):2761-4. PubMed ID: 30958
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of once daily beta-adrenoceptor blocker-thiazide diuretic combination on the ambulatory blood pressure.
    Gould BA; Hornung RS; Kieso H; Mann S; Raftery EB
    Br J Clin Pharmacol; 1982 Dec; 14(6):827-31. PubMed ID: 6129883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.
    Lancaster R; Goodwin TJ; Peart WS
    Br J Clin Pharmacol; 1976 Jun; 3(3):453-60. PubMed ID: 973972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of hypertension with beta-blockers with and without intrinsic sympathomimetic activity.
    Hansson L; Svensson A; Gudbrandsson T; Sivertsson R
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S26-9. PubMed ID: 6188917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
    Luomanmäki K; Hartikainen M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S63-7. PubMed ID: 2423800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of essential hypertension with pindolol.
    Bloem TJ; Kerkhof JV
    Cardiology; 1978; 63(3):168-74. PubMed ID: 346223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Sievert A; Aurell M; Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S102-4. PubMed ID: 2455104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First-step treatment of mild to moderate uncomplicated essential hypertension by a new calcium antagonist: nicardipine.
    Bellet M; Loria Y; Lallemand A
    J Cardiovasc Pharmacol; 1985; 7(6):1149-53. PubMed ID: 2418302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.
    van den Meiracker AH; Man in't Veld AJ; Schalekamp MA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):39S-44S. PubMed ID: 3326634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of long-term administration of two beta-blocking agents on myocardial structure in spontaneously hypertensive rats.
    Monopoli A; Ongini E; Lagrasta C; Ricci R; Olivetti G
    Arch Int Pharmacodyn Ther; 1991; 313():129-39. PubMed ID: 1840090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.